HealthBayer Seeks FDA Approval For Regorafenib As Liver Cancer Treatment German drugmaker Bayer on Monday submitted an sNDA proposal to the FDA for the extension of its drug Regorafenib as a second-line treatment for liver cancer. The drug is currently used to treat colorectal cancer.by Alyssa Navarro
Healthy Living/WellnessStudy Raises Safety Concern About Bayer Sterilization Device: Essure Tied With Increased Need For Reoperationsby Julienne Roman
Healthy Living/WellnessReports Of Health Complications Prompt FDA To Review Safety Of Essure Birth Control Implantby Julienne Roman
Healthy Living/WellnessBayer Pushes Heart Failure Drug Finerenone To Final-Stage Trialsby Rina Marie Doctor
Healthy Living/WellnessCourt awards Chicago woman $14 mn in damages after taking wrongly prescribed Yasmin contraceptiveby Rhodi Lee
Healthy Living/WellnessProstate cancer drug Xofigo not recommended by British authorities due to cost effectiveness issuesby Lori Sandoval